Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-22 | Stephen C. Farrell |
| 2013-10-07 | Mr. Farrell currently serves as Chief Executive Officer and Director of Convey Health Solutions (formerly known as NationsHealth, Inc.), a healthcare business process outsourcing company headquartered in Sunrise, Florida. Convey Health Solutions utilizes both technology and staff to manage end-to-end insurance processes for business clients. |
| 2014-10-14 | Mr. Farrell currently serves as Chief Executive Officer and Director of Convey Health Solutions, a healthcare business process outsourcing company. |
| 2015-06-11 | Mr. Farrell holds an A.B. from Harvard University, and an M.B.A. from the Darden School at the University of Virginia. |
| 2016-04-29 | Mr. Farrell currently serves as Chief Executive Officer and Director of Convey Health Solutions, a healthcare business process outsourcing company. |
| 2017-05-01 | Mr. Farrell holds an A.B. from Harvard University, and an M.B.A. from the Darden School at the University of Virginia. |
| 2018-03-29 | Mr. Farrell holds an A.B. from Harvard University, and an M.B.A. from the Darden School at the University of Virginia. |
| 2019-06-14 | Mr. Farrell holds an A.B. from Harvard University, and an M.B.A. from the Darden School at the University of Virginia. Mr. Farrell currently serves as a director of STAAR Surgical Company, a designer and developer of implantable lenses for the eye. Mr. Farrell brings to our Board significant experience in finance, financial reporting, accounting and auditing, and in management as a senior executive of a public healthcare company during a period of significant growth. |
| 2020-08-07 | Mr. Farrell holds an A.B. from Harvard University, and an M.B.A. from the Darden School at the University of Virginia. Mr. Farrell brings to our Board significant experience in finance, financial reporting, accounting, and auditing, and in management as a senior executive of a public healthcare company. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-05-02 | Mr. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Directors of Convey Health Solutions, a private equity sponsored technology-enabled healthcare business process outsourcer. ... Awards granted to Messrs. Wall and Farrell were pro-rated based upon the date of their appointment to the Board. ... Mr. Farrell was elected to serve as a director of the Company effective January 1, 2016. |
| 2017-05-01 | Stephen C. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Director of Convey Health Solutions. Age 52. The Audit Committee are Stephen C. Farrell who serves as chair, John C. Moore, and William P. Wall. Mr. Farrell was chair of the Audit and Corporate Citizenship Committees for Questcor Pharmaceuticals and BioTime, Inc. 2016 Director Compensation: Stephen C. Farrell total $151,799. |
| 2018-04-26 | Stephen C. Farrell Director since January 2016 Age 53 Background. Mr. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Director of Convey Health Solutions, a private equity sponsored technology-enabled healthcare business process outsourcer. Also, since 2012 he has served as a member of the Board of Directors of BioTime, Inc., a clinical stage biotechnology company focused in the field of regenerative medicine. From 2008 to 2009, Mr. Farrell served as the Executive Vice President and Chief Financial Officer for Stream Global Services, a business process outsourcer. From 1999 to 2007, Mr. Farrell served as President of PolyMedica Corporation, a publicly traded provider of diabetes supplies that was acquired by Medco Health Solutions in 2007. From 2007 to 2014, he served as a member of the Board of Directors of Questcor Pharmaceuticals, a biopharmaceutical company that was acquired by Mallinckrodt PLC. Mr. Farrell spent five years as a Senior Manager at PricewaterhouseCoopers auditing leading public companies from 1994 to 1999. He received his B.A. from Harvard University and earned a M.B.A. at the University of Virginia, Darden School of Business. Qualifications. The Board of Directors concluded that Mr. Farrell should serve on the Board of Directors because he brings significant operating, financial and board experience to STAAR. He has a strong knowledge of healthcare, having led PolyMedica and Convey Health Solutions, and having served as Chairman of the Audit and Corporate Citizenship Committees for Questcor Pharmaceuticals and BioTime, Inc., and also would qualify as a financial expert. His expertise in healthcare distribution, accounting and financial stewardship will add a valuable skill set and strategic perspective to our Board. Committee Composition: Audit Committee Nominating, Governance Committee All of the directors listed in the chart are independent directors under the rules of the Securities and Exchange Commission and the Nasdaq Marketplace Rules, with the exception of Caren Mason, who serves as STAAR’s President and Chief Executive Officer. 2017 Director Compensation Stephen C. Farrell Fees Earned or Paid in Cash ($): 65,000 Option Awards ($): 99,939 Stock Awards ($): — Total ($): 164,939 |
| 2019-04-29 | Stephen C. Farrell Director since January 2016 Age 54 Background. Mr. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Directors of Convey Health Solutions, a private equity sponsored technology-enabled healthcare business process outsourcer. The current members of the Audit Committee are Stephen C. Farrell who serves as chair, John C. Moore, and William P. Wall. The current members of the Nominating and Governance Committee are William P. Wall, who serves as chair, Stephen C. Farrell and Louis E. Silverman. 2018 Director Compensation The table below summarizes the fiscal 2018 compensation of each non-employee director, including fees earned or paid in cash, restricted stock awards and stock options. Stephen C. Farrell Fees Earned or Paid in Cash ($): 67,335 Option Awards ($): 9,982 Stock Awards ($): 109,992 Total: 187,309 |
| 2020-06-08 | Stephen C. Farrell\nDirector since January 2016\nAge 55\n...\nThe current members of the Audit Committee are Stephen C. Farrell who serves as chair, John C. Moore, and Louis E. Silverman.\n...\nThe current members of the Nominating and Governance Committee are Stephen C. Farrell and Louis E. Silverman, who serves as interim chair.\n...\n2019 Director Compensation \nThe table below summarizes the fiscal 2019 compensation of each non-employee director, including fees earned or paid in cash, restricted stock awards and stock options.\nName\nStephen C. Farrell\nFees Earned or Paid in Cash ($)\n78,393\nOption Awards ($)\n125,003\nStock Awards ($)\n—\nTotal\n203,396 |
| 2021-04-30 | Stephen C. Farrell Director since January 2016 Age 56 ... The current members of the Audit Committee are Stephen C. Farrell who serves as chair ... The current members of the Nominating and Governance Committee are Dr. Gilbert H. Kliman, Stephen C. Farrell and Louis E. Silverman ... 2020 Director Compensation ... Stephen C. Farrell Fees Earned or Paid in Cash 75,000 Option Awards — Stock Awards 125,030 Total 200,030 |
| 2022-04-29 | Stephen C. Farrell Director since January 2016 Age 57 Qualifications. The Board of Directors concluded that Mr. Farrell should serve on the Board of Directors because he brings significant operating, financial and board experience to STAAR. He has a strong knowledge of healthcare, having led PolyMedica and Convey Health Solutions, and having served as Chair of the Audit and Corporate Citizenship Committees for Questcor Pharmaceuticals and Lineage Cell Therapeutics, and also would qualify as a financial expert. His expertise in healthcare distribution, accounting and financial stewardship will add a valuable skill set and strategic perspective to our Board. 2021 Director Compensation Stephen C. Farrell Fees Earned or Paid in Cash ($): 75,000 Option Awards ($): 62,402 Stock Awards ($): 117,615 Total: 255,017 |
| 2023-04-26 | Stephen C. Farrell Director since January 2016 Age 58 ... Mr. Farrell did not receive a stock award in 2022. As of the end of fiscal year 2022, the aggregate number of option awards outstanding for Mr. Farrell were 56,198. ... The Board announced the creation of the role of Lead Independent Director and appointed Mr. Stephen Farrell to serve in that capacity, effective January 1, 2023. Mr. Farrell will receive an additional $40,000 per year as compensation in connection with his service as the Lead Independent. ... 2022 Director Compensation ... Stephen C. Farrell Fees Earned or Paid in Cash $75,000 Option Awards $180,009 Total $255,009 ... Audit Committee Chair Additional Retainer $15,000 ... Board of Directors Chair Additional Retainer $40,000 ... Members of the Audit Committee Additional Retainer $10,000. |
| 2024-04-24 | Mr. Farrell earned a B.A. from Harvard University and an M.B.A. at the University of Virginia, Darden School of Business. |
Data sourced from SEC filings. Last updated: 2025-10-12